Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Organisation › Details

ARCH Venture Partners

ARCH Venture Partners is one of the largest early stage technology venture firms in the U.S. ARCH has co-founded and provided initial investments for more than 250 companies organized around innovations from research universities, national laboratories, corporate research groups and entrepreneurs. By focusing on leading scientific innovators, ARCH has been at the forefront of investing in major areas of innovation in the life sciences and physical sciences, and has helped to catalyze revolutionary advances in genomics, nanotechnology, industrial biotechnology and major disease treatments. ARCH has raised ten primary funds with combined committed capital at the time raised of approximately $4.5 billion. *


Period Start 1986-01-01 established
  Group ARCH Venture (Group)
Product Industry venture capital
Person Person Gillis, Steven (ARCH Venture Partners 200603 Venture Partner before co-founder + CEO Corixa before co-founder Immunex)
Region Region Chicago, IL
  Country United States (USA)
  Street 8725 W. Higgins Road.
Suite 290
  City 60631 Chicago, IL
  Tel +1-773-380-6600
    Address record changed: 2020-12-02
Basic data Employees n. a.
  Currency USD
  Annual sales 2,500,000,000 (funds, managed 2017-03-16)
    * Document for »About Section«: Vizgen. (1/30/20). "Press Release: Vizgen Launches with $14M Series A Financing Led by ARCH Venture Partners and Northpond Ventures". Cambridge, MA.
Record changed: 2024-05-05


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for ARCH Venture (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top